Kymera Therapeutics, Inc. (KYMR)
- Previous Close
34.27 - Open
34.04 - Bid 34.09 x 100
- Ask 34.74 x 100
- Day's Range
32.75 - 34.99 - 52 Week Range
19.44 - 53.27 - Volume
199,759 - Avg. Volume
713,639 - Market Cap (intraday)
2.239B - Beta (5Y Monthly) 2.23
- PE Ratio (TTM)
-- - EPS (TTM)
-2.98 - Earnings Date May 9, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
57.67
Kymera Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing small molecule therapeutics that selectively degrade disease-causing proteins by harnessing the body's own natural protein degradation system. It engages in developing IRAK4 program, which is in Phase II clinical trial for the treatment of immunology-inflammation diseases, including hidradenitis suppurativa and atopic dermatitis. The company also develops STAT6, a type 2 inflammation in allergic and atopic diseases; and TYK2 to treat autoimmune and inflammatory diseases. Kymera Therapeutics, Inc. was incorporated in 2015 and is headquartered in Watertown, Massachusetts.
www.kymeratx.comRecent News: KYMR
View More
Performance Overview: KYMR
Trailing total returns as of 5/1/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: KYMR
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: KYMR
View MoreValuation Measures
Market Cap
2.22B
Enterprise Value
1.82B
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
54.60
Price/Book (mrq)
2.67
Enterprise Value/Revenue
38.74
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
0.00%
Return on Assets (ttm)
-20.65%
Return on Equity (ttm)
-36.38%
Revenue (ttm)
47.07M
Net Income Avi to Common (ttm)
-223.86M
Diluted EPS (ttm)
-2.98
Balance Sheet and Cash Flow
Total Cash (mrq)
488.74M
Total Debt/Equity (mrq)
10.50%
Levered Free Cash Flow (ttm)
-126.83M
Research Analysis: KYMR
View MoreResearch Reports: KYMR
View MoreDaily – Vickers Top Buyers & Sellers for 11/07/2023
The Vickers Top Buyers & Sellers is a daily report that identifies the five companies the largest insider purchase transactions based on the dollar value of the transactions as well as the five companies the largest insider sales transactions based on the dollar value of the transactions.
Daily – Vickers Top Buyers & Sellers for 01/17/2023
The Vickers Top Buyers & Sellers is a daily report that identifies the five companies the largest insider purchase transactions based on the dollar value of the transactions as well as the five companies the largest insider sales transactions based on the dollar value of the transactions.
Daily – Vickers Top Buyers & Sellers for 06/01/2022
The Vickers Top Buyers & Sellers is a daily report that identifies the five companies the largest insider purchase transactions based on the dollar value of the transactions as well as the five companies the largest insider sales transactions based on the dollar value of the transactions.
Daily – Vickers Top Buyers & Sellers for 05/10/2022
The Vickers Top Buyers & Sellers is a daily report that identifies the five companies the largest insider purchase transactions based on the dollar value of the transactions as well as the five companies the largest insider sales transactions based on the dollar value of the transactions.